Bayer plans further expansion in Asia

The Bayer Group plans to further expand its production, distribution network and research activities in Asia and considerably increase its sales in the region by as much as 60% by 2015. This was announced during Bayer's international press conference with theme, "Perspective on Growth in Asia," held in Shanghai, China. Also inaugurated is a new production facility for TDI - a raw material for the production of flexible foams - at the Bayer Integrated Site Shanghai.
All the Asian countries are intended to play a part in achieving the sales increase targeted for 2015. Apart from China, sales in India and Japan are expected to rise. In addition, Bayer intends to participate in the region's transition to become an innovation hub of the globalised world. Here the company is focusing on collaborations with the leading institutes and centres of expertise, as well as its own activities. Bayer also wants to improve access to its new medicines in Asia by integrating Asian patients into the early stages of global development programs, and plans to submit innovative medicines for registration concurrently in Asia, Europe and the United States. Bayer MaterialScience not only supplies industrial customers with locally manufactured polymer products, it also offers the necessary technical advice and applications development know-how through its systems houses.
www.bayer.com